Commonly done in practice for stomach protection due to risk for gastric ulcers. Etoricoxib is not approved in US for use, closest would be celecoxib or Celebrex, and its potential to cause gastric ulcers is less than the risk with non selective NSAIDS.
Answered 6/7/2021
0 views
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question